Check out the technologies actively seeking match through Founder Factory! To be matched to these technologies, please join us April 23rd for our Idea to Enterprise Pitch Night.
OTT 1894: Ultra‑Rapid On‑Site Detection of Foodborne Pathogens
Help evaluate the commercial potential of a rapid food‑safety testing innovation designed to deliver actionable results in minutes rather than days. We’re seeking participants with experience in food processing, meat or poultry operations, quality assurance, or food‑safety procurement to explore market fit, adoption challenges, and viable paths to venture creation.
OTT 1871: Low‑Cost Surface Alloying for Copper & Brass Castings
Explore the venture potential of a manufacturing innovation that delivers premium surface performance in copper and brass castings—without the cost of full‑section alloying. We’re inviting people with insight into casting, plumbing hardware, water systems, or industrial manufacturing to help assess market demand, adoption pathways, and startup opportunities.
OTT 1853: Secure‑by‑Design AI for Edge Devices
Join an exploratory team evaluating a lightweight technology that protects AI running on cameras, robots, and sensors from hidden attacks—without slowing systems down or requiring model retraining. This opportunity is ideal for people with experience in AI deployment, industrial automation, smart devices, or enterprise software markets who want to help shape a venture‑ready concept.
Adaptive Dose‑Tracking Software for Radiation Therapy
Help evaluate a software innovation that accurately tracks radiation dose as patient anatomy changes—offering safer, more precise treatment assessment than static dose‑summation methods. Perfect for participants with experience in radiation oncology, medical imaging, clinical software, or digital health to examine market fit and startup potential.
AR‑Guided MRI Procedures
Help explore the startup potential of an augmented‑reality system that gives clinicians “GPS‑like” visualization during MRI‑guided needle procedures—improving accuracy, speed, and workflow efficiency. Ideal for those with expertise in medical imaging, AR‑surgical tools, interventional device markets, or clinical workflow innovation to assess adoption pathways and commercialization opportunities.
Explainable AI via Functional Activation Analysis
Join a team evaluating a novel approach that reveals how deep neural networks actually behave—using structured inputs and neuroimaging‑inspired statistical modeling to decode layer‑specific activity without retraining. Great for people with backgrounds in AI/ML, model interpretability, enterprise AI adoption, or developer tooling to explore commercial fit and venture development.
Next‑Generation Lyme Disease Vaccine
Join an exploratory team assessing a vaccine designed to deliver broader, longer‑lasting protection against Lyme disease by pairing OspA with a novel immune‑boosting carrier. A strong match for contributors with experience in vaccines, animal health, infectious‑disease markets, or public‑health innovation to evaluate market demand and venture feasibility.
Lipid Lowering Peptide
A New Biologic Approach for Better Lipoprotein Control in Cardiovascular Disease
Many patients still face significant cardiovascular risk even after taking standard cholesterol drugs. Statins and PCSK9 inhibitors mainly lower LDL, but other harmful lipoproteins often remain.
Researchers at the Versiti Blood Research Institute have created tPA K2, a next generation lipid‑lowering peptide designed to reduce all atherogenic apoB lipoproteins at their source. Early studies show that it delivers broad lipid reduction without causing liver fat buildup or increasing bleeding risk, which has been a major challenge for past approaches.
Next‑Generation Intranasal Antiviral Platform
Explore the venture opportunity behind a platform that anchors potent antiviral proteins directly to airway cells for long‑lasting, front‑line protection against respiratory viruses. Ideal for contributors with experience in antivirals, infectious‑disease markets, platform therapeutics, or respiratory‑care innovation to help assess market need, scalability, and viable paths to a startup.